A global policy would reward firms which strive for higher quality.
The US Food and Drug Administration (FDA) says it does not follow an India agenda.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances